10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 223 filers reported holding 10X GENOMICS INC in Q3 2020. The put-call ratio across all filers is 0.25 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,885,503 | -35.4% | 94,194 | -12.6% | 0.01% | -25.0% |
| Q2 2023 | $6,016,146 | +6.1% | 107,739 | +6.0% | 0.01% | 0.0% |
| Q1 2023 | $5,670,049 | +50.9% | 101,632 | -1.4% | 0.01% | +33.3% |
| Q4 2022 | $3,757,802 | +20.7% | 103,123 | -5.7% | 0.01% | +20.0% |
| Q3 2022 | $3,113,000 | -37.8% | 109,300 | -1.2% | 0.01% | -37.5% |
| Q2 2022 | $5,007,000 | -50.7% | 110,645 | -17.2% | 0.01% | -38.5% |
| Q1 2022 | $10,164,000 | -51.7% | 133,618 | -5.4% | 0.01% | -48.0% |
| Q4 2021 | $21,030,000 | +4.1% | 141,178 | +1.7% | 0.02% | -3.8% |
| Q3 2021 | $20,202,000 | -31.5% | 138,766 | -7.9% | 0.03% | -29.7% |
| Q2 2021 | $29,496,000 | +49.0% | 150,630 | +37.7% | 0.04% | +42.3% |
| Q1 2021 | $19,799,000 | +28.0% | 109,389 | +0.2% | 0.03% | +18.2% |
| Q4 2020 | $15,466,000 | +22.5% | 109,225 | +7.8% | 0.02% | +10.0% |
| Q3 2020 | $12,630,000 | +51.0% | 101,302 | +8.1% | 0.02% | +33.3% |
| Q2 2020 | $8,366,000 | – | 93,670 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |